Cocrystal Pharma's total assets for Q4 2025 were $9.71M, a decrease of -7.03% from the previous quarter. COCP total liabilities were $3.38M for the fiscal quarter, a 21.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.